• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC QUANTUM APEX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC QUANTUM APEX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 6533
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/13/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Date of event: used the first day of the month of the aware date since event date was not provided.
 
Event or Problem Description
It was reported that balloon rupture occurred.The target lesion was located in the anterior descending artery.A 20mm x 3.75mm nc quantum apex balloon catheter was advanced for dilation.However, during the inflation at 16 atmospheres, the balloon ruptured.The procedure was completed with no patient complications reported.
 
Additional Manufacturer Narrative
B3 - date of event corrected from 12/01/2021 to (b)(6) 2022.
 
Event or Problem Description
It was reported that balloon rupture occurred.The target lesion was located in the anterior descending artery.A 20mm x 3.75mm nc quantum apex balloon catheter was advanced for dilation.However, during the inflation at 16 atmospheres, the balloon ruptured.The procedure was completed with no patient complications reported.
 
Event or Problem Description
It was reported that balloon rupture occurred.The target lesion was located in the anterior descending artery.A 20mm x 3.75mm nc quantum apex balloon catheter was advanced for dilation.However, during the inflation at 16 atmospheres, the balloon ruptured.The procedure was completed with no patient complications reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an nc quantum apex balloon catheter.The device was visually and microscopically examined.There was contrast in the inflation lumen.At 10.6cm from the tip of the device, the guidewire lumen was punctured exposing the inflation lumen which would cause device leakage.The damage indicates an interaction with a guidewire.The balloon was loosely folded, and the tip of the device was damaged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC QUANTUM APEX
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13143810
Report Number2134265-2021-16394
Device Sequence Number4650916
Product Code LOX
UDI-Device Identifier08714729783510
UDI-Public08714729783510
Combination Product (Y/N)N
Initial Reporter CountryCO
PMA/510(K) Number
K121667
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/18/2023
Device Model Number6533
Device Catalogue Number6533
Device Lot Number0026540217
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/16/2021
Supplement Date Received by Manufacturer01/04/2022
03/01/2022
Initial Report FDA Received Date01/03/2022
Supplement Report FDA Received Date01/14/2022
03/04/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/18/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-